Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease

Richard L Sweet, D. V. Landers, J. Schachter, W. R. Crombleholme

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Acute pelvic inflammatory disease is associated with significant adverse reproductive sequelae. To prevent these serious sequelae, treatment regimens must cover the major etiologic agents which are Neisseria gonorrhoeae, Chlamydia trachomatis, and mixed anaerobic-aerobic bacteria. This report concerns the prospective evaluation of the efficacy of the combination of sulbactam with ampicillin in patients hospitalized with acute pelvic inflammatory disease. Clinical cure was noted in 33 (94%) of 35 patients and post-treatment cultures demonstrated eradication of N. gonorrhoeae and C. trachomatis in all cases.

Original languageEnglish (US)
Pages (from-to)13-19
Number of pages7
JournalInternational Journal of Gynecology and Obstetrics
Issue numberSUPPL.
StatePublished - 1989


  • Ampicillin
  • Ectopic pregnancy
  • Infertility
  • Pelvic inflammatory disease
  • Sulbactam

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)


Dive into the research topics of 'Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease'. Together they form a unique fingerprint.

Cite this